Back
Acumen Pharmaceuticals 10K Form
Sell
14
ABOS
Acumen Pharmaceuticals
Last Price:
2.35
Seasonality Move:
-0.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ABOS News And Ratings
See the #1 stock for the next 7 days that we like better than ABOS
ABOS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.44M |
|---|---|
| Cash Flow: | $-24.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.62 |
| Price / Book: | 0.66 |
Profitability
| EPS (TTM): | -1.38000 |
|---|---|
| Net Income (TTM): | $-81.67M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Acumen Pharmaceuticals Earnings Forecast
Key Acumen Pharmaceuticals Financial Ratios
- The Interest Expense is -1.11% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Acumen Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABOS |
| Website: | acumenpharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABOS Technical Analysis vs Fundamental Analysis
Sell
14
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a Sell
The current Acumen Pharmaceuticals [ABOS] share price is $2.37. The Score for ABOS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.